HEADER    PROTEIN FIBRIL                          28-JUN-16   5KO0              
TITLE     HUMAN ISLET AMYLOID POLYPEPTIDE SEGMENT 15-FLVHSSNNFGA-25 DETERMINED  
TITLE    2 BY MICROED                                                           
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: HIAPP(15-25)WT;                                            
COMPND   3 CHAIN: A, B;                                                         
COMPND   4 SYNONYM: AMYLIN, DIABETES-ASSOCIATED PEPTIDE, DAP, INSULINOMA AMYLOID
COMPND   5 PEPTIDE;                                                             
COMPND   6 ENGINEERED: YES;                                                     
COMPND   7 OTHER_DETAILS: ISLET AMYLOID                                         
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 SYNTHETIC: YES;                                                      
SOURCE   3 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   4 ORGANISM_COMMON: HUMAN;                                              
SOURCE   5 ORGANISM_TAXID: 9606                                                 
KEYWDS    AMYLOID, ISLET AMYLOID POLYPEPTIDE, TYPE II DIABETES, TOXIC SPINE,    
KEYWDS   2 MICROED, PROTEIN FIBRIL                                              
EXPDTA    ELECTRON CRYSTALLOGRAPHY                                              
AUTHOR    P.A.L.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,D.SHI,B.L.NANNENGA,    
AUTHOR   2 J.HATTNE,F.E.REYES,T.GONEN,D.S.EISENBERG                             
REVDAT   7   30-JUN-21 5KO0    1       REMARK                                   
REVDAT   6   20-NOV-19 5KO0    1       REMARK                                   
REVDAT   5   04-SEP-19 5KO0    1       JRNL                                     
REVDAT   4   06-JUN-18 5KO0    1       REMARK                                   
REVDAT   3   25-APR-18 5KO0    1       REMARK                                   
REVDAT   2   13-SEP-17 5KO0    1       REMARK                                   
REVDAT   1   21-DEC-16 5KO0    0                                                
JRNL        AUTH   P.KROTEE,J.A.RODRIGUEZ,M.R.SAWAYA,D.CASCIO,F.E.REYES,D.SHI,  
JRNL        AUTH 2 J.HATTNE,B.L.NANNENGA,M.E.OSKARSSON,S.PHILIPP,S.GRINER,      
JRNL        AUTH 3 L.JIANG,C.G.GLABE,G.T.WESTERMARK,T.GONEN,D.S.EISENBERG       
JRNL        TITL   ATOMIC STRUCTURES OF FIBRILLAR SEGMENTS OF HIAPP SUGGEST     
JRNL        TITL 2 TIGHTLY MATED BETA-SHEETS ARE IMPORTANT FOR CYTOTOXICITY.    
JRNL        REF    ELIFE                         V.   6       2017              
JRNL        REFN                   ESSN 2050-084X                               
JRNL        PMID   28045370                                                     
JRNL        DOI    10.7554/ELIFE.19273                                          
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.40 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : PHENIX                                               
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN            
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,           
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,            
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,              
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,               
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,           
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT                  
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART                  
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : NULL                                          
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 9.75                           
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 2.010                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 75.6                           
REMARK   3   NUMBER OF REFLECTIONS             : 2177                           
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.229                           
REMARK   3   R VALUE            (WORKING SET) : 0.225                           
REMARK   3   FREE R VALUE                     : 0.259                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.010                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 218                             
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).                           
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE        
REMARK   3     1  9.7490 -  1.7605    0.82     1062   119  0.2152 0.2401        
REMARK   3     2  1.7605 -  1.4000    0.69      897    99  0.2506 0.3155        
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED        : NULL                                          
REMARK   3   SOLVENT RADIUS     : 1.11                                          
REMARK   3   SHRINKAGE RADIUS   : 0.90                                          
REMARK   3   K_SOL              : NULL                                          
REMARK   3   B_SOL              : NULL                                          
REMARK   3                                                                      
REMARK   3  ERROR ESTIMATES.                                                    
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.210            
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 29.830           
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 7.76                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 9.03                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  TWINNING INFORMATION.                                               
REMARK   3   FRACTION: NULL                                                     
REMARK   3   OPERATOR: NULL                                                     
REMARK   3                                                                      
REMARK   3  DEVIATIONS FROM IDEAL VALUES.                                       
REMARK   3                 RMSD          COUNT                                  
REMARK   3   BOND      :  0.008            176                                  
REMARK   3   ANGLE     :  1.216            235                                  
REMARK   3   CHIRALITY :  0.047             24                                  
REMARK   3   PLANARITY :  0.004             32                                  
REMARK   3   DIHEDRAL  : 12.170             52                                  
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  NCS DETAILS                                                         
REMARK   3   NUMBER OF NCS GROUPS : NULL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 5KO0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-16.                  
REMARK 100 THE DEPOSITION ID IS D_1000222506.                                   
REMARK 240                                                                      
REMARK 240 EXPERIMENTAL DETAILS                                                 
REMARK 240   RECONSTRUCTION METHOD          : CRYSTALLOGRAPHY                   
REMARK 240   SAMPLE TYPE                    : 3D ARRAY                          
REMARK 240   SPECIMEN TYPE                  : NULL                              
REMARK 240 DATA ACQUISITION                                                     
REMARK 240   DATE OF DATA COLLECTION        : 04-NOV-14                         
REMARK 240   TEMPERATURE           (KELVIN) : 100.0                             
REMARK 240   PH                             : NULL                              
REMARK 240   NUMBER OF CRYSTALS USED        : NULL                              
REMARK 240   MICROSCOPE MODEL               : FEI TECNAI 20                     
REMARK 240   DETECTOR TYPE                  : TVIPS TEMCAM-F416 (4K X 4K)       
REMARK 240   ACCELERATION VOLTAGE (KV)      : 200                               
REMARK 240   NUMBER OF UNIQUE REFLECTIONS   : 2180                              
REMARK 240   RESOLUTION RANGE HIGH      (A) : 1.400                             
REMARK 240   RESOLUTION RANGE LOW       (A) : 17.733                            
REMARK 240   DATA SCALING SOFTWARE          : XSCALE                            
REMARK 240   COMPLETENESS FOR RANGE     (%) : 75.0                              
REMARK 240   DATA REDUNDANCY                : NULL                              
REMARK 240 IN THE HIGHEST RESOLUTION SHELL                                      
REMARK 240   HIGHEST RESOLUTION SHELL, RANGE HIGH (A) :1.40                     
REMARK 240   HIGHEST RESOLUTION SHELL, RANGE LOW  (A) :1.44                     
REMARK 240   COMPLETENESS FOR SHELL     (%) : 35.3                              
REMARK 240   DATA REDUNDANCY IN SHELL       : NULL                              
REMARK 240   R MERGE FOR SHELL          (I) : 0.50500                           
REMARK 240   METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT      
REMARK 240   SOFTWARE USED                  : PHASER 2.5.6                      
REMARK 240   STARTING MODEL                 : NULL                              
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1                              
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 300 REMARK: THE BIOLOGICAL UNIT IS AN EXTENDED BETA SHEET COMPRISING     
REMARK 300 PEPTIDES REPEATED AD INFINITUM ALONG THE A CRYSTAL AXIS.             
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: OCTADECAMERIC                     
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   2  1.000000  0.000000  0.000000      -46.72000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   2  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   3  1.000000  0.000000  0.000000      -35.04000            
REMARK 350   BIOMT2   3  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   4  1.000000  0.000000  0.000000      -23.36000            
REMARK 350   BIOMT2   4  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   4  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   5  1.000000  0.000000  0.000000      -11.68000            
REMARK 350   BIOMT2   5  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   5  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   6  1.000000  0.000000  0.000000       11.68000            
REMARK 350   BIOMT2   6  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   6  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   7  1.000000  0.000000  0.000000       23.36000            
REMARK 350   BIOMT2   7  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   7  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   8  1.000000  0.000000  0.000000       35.04000            
REMARK 350   BIOMT2   8  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   8  0.000000  0.000000  1.000000        0.00000            
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B                                  
REMARK 350   BIOMT1   9  1.000000  0.000000  0.000000       46.72000            
REMARK 350   BIOMT2   9  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   9  0.000000  0.000000  1.000000        0.00000            
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue SCN B 101                 
REMARK 900                                                                      
REMARK 900 RELATED ENTRIES                                                      
REMARK 900 RELATED ID: EMD-8273   RELATED DB: EMDB                              
REMARK 900 RELATED ID: EMD-8272   RELATED DB: EMDB                              
REMARK 900 RELATED ID: 5KNZ   RELATED DB: PDB                                   
DBREF  5KO0 A   15    25  UNP    P10997   IAPP_HUMAN      48     58             
DBREF  5KO0 B   15    25  UNP    P10997   IAPP_HUMAN      48     58             
SEQRES   1 A   11  PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA                  
SEQRES   1 B   11  PHE LEU VAL HIS SER SER ASN ASN PHE GLY ALA                  
HET    SCN  B 101       3                                                       
HETNAM     SCN THIOCYANATE ION                                                  
FORMUL   3  SCN    C N S 1-                                                     
FORMUL   4  HOH   *6(H2 O)                                                      
SHEET    1 AA1 2 LEU A  16  GLY A  24  0                                        
SHEET    2 AA1 2 LEU B  16  GLY B  24 -1  O  VAL B  17   N  PHE A  23           
SITE     1 AC1  2 ASN A  22  SER B  19                                          
CRYST1   11.680   18.180   19.930  62.84  88.90  87.60 P 1           2          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.085616 -0.003584 -0.000010        0.00000                         
SCALE2      0.000000  0.055054 -0.028217        0.00000                         
SCALE3      0.000000  0.000000  0.056392        0.00000                         
ATOM      1  N   PHE A  15       6.228  -6.806  -8.952  1.00 13.92           N  
ATOM      2  CA  PHE A  15       4.932  -6.630  -8.313  1.00 11.43           C  
ATOM      3  C   PHE A  15       4.946  -5.440  -7.376  1.00  6.45           C  
ATOM      4  O   PHE A  15       5.998  -5.044  -6.883  1.00 10.20           O  
ATOM      5  CB  PHE A  15       4.531  -7.882  -7.526  1.00 11.60           C  
ATOM      6  CG  PHE A  15       5.346  -8.097  -6.278  1.00 13.43           C  
ATOM      7  CD1 PHE A  15       4.925  -7.585  -5.059  1.00 17.62           C  
ATOM      8  CD2 PHE A  15       6.537  -8.799  -6.327  1.00 13.96           C  
ATOM      9  CE1 PHE A  15       5.675  -7.766  -3.921  1.00  8.36           C  
ATOM     10  CE2 PHE A  15       7.289  -8.988  -5.182  1.00 18.33           C  
ATOM     11  CZ  PHE A  15       6.855  -8.474  -3.982  1.00 14.08           C  
ATOM     12  N   LEU A  16       3.761  -4.879  -7.142  1.00  9.53           N  
ATOM     13  CA  LEU A  16       3.560  -3.891  -6.090  1.00  8.17           C  
ATOM     14  C   LEU A  16       2.379  -4.247  -5.236  1.00  6.69           C  
ATOM     15  O   LEU A  16       1.278  -4.389  -5.742  1.00 10.98           O  
ATOM     16  CB  LEU A  16       3.302  -2.511  -6.655  1.00 10.91           C  
ATOM     17  CG  LEU A  16       3.328  -1.269  -5.767  1.00 11.03           C  
ATOM     18  CD1 LEU A  16       4.701  -1.049  -5.160  1.00 15.61           C  
ATOM     19  CD2 LEU A  16       2.905  -0.057  -6.587  1.00 17.06           C  
ATOM     20  N   VAL A  17       2.587  -4.358  -3.936  1.00  5.28           N  
ATOM     21  CA  VAL A  17       1.450  -4.442  -3.039  1.00  4.23           C  
ATOM     22  C   VAL A  17       1.255  -3.028  -2.509  1.00  3.45           C  
ATOM     23  O   VAL A  17       2.236  -2.335  -2.229  1.00  5.11           O  
ATOM     24  CB  VAL A  17       1.682  -5.449  -1.903  1.00  7.10           C  
ATOM     25  CG1 VAL A  17       0.508  -5.487  -0.943  1.00 14.13           C  
ATOM     26  CG2 VAL A  17       1.959  -6.829  -2.484  1.00  6.68           C  
ATOM     27  N   HIS A  18       0.011  -2.574  -2.391  1.00  4.46           N  
ATOM     28  CA  HIS A  18      -0.224  -1.206  -1.954  1.00  6.38           C  
ATOM     29  C   HIS A  18      -1.525  -1.124  -1.217  1.00  1.91           C  
ATOM     30  O   HIS A  18      -2.426  -1.926  -1.441  1.00  3.20           O  
ATOM     31  CB  HIS A  18      -0.261  -0.248  -3.135  1.00  3.54           C  
ATOM     32  CG  HIS A  18      -1.265  -0.638  -4.167  1.00 10.19           C  
ATOM     33  ND1 HIS A  18      -2.588  -0.260  -4.095  1.00 10.38           N  
ATOM     34  CD2 HIS A  18      -1.155  -1.420  -5.267  1.00 13.18           C  
ATOM     35  CE1 HIS A  18      -3.245  -0.772  -5.120  1.00 14.15           C  
ATOM     36  NE2 HIS A  18      -2.399  -1.479  -5.846  1.00 15.29           N  
ATOM     37  N   SER A  19      -1.620  -0.136  -0.345  1.00  2.35           N  
ATOM     38  CA  SER A  19      -2.835   0.139   0.378  1.00  3.26           C  
ATOM     39  C   SER A  19      -2.957   1.650   0.535  1.00  2.18           C  
ATOM     40  O   SER A  19      -1.950   2.358   0.594  1.00  4.28           O  
ATOM     41  CB  SER A  19      -2.823  -0.568   1.733  1.00  3.43           C  
ATOM     42  OG  SER A  19      -1.799  -0.050   2.556  1.00  9.19           O  
ATOM     43  N   SER A  20      -4.188   2.142   0.575  1.00  5.10           N  
ATOM     44  CA  SER A  20      -4.445   3.550   0.842  1.00  3.90           C  
ATOM     45  C   SER A  20      -5.680   3.664   1.720  1.00  3.11           C  
ATOM     46  O   SER A  20      -6.550   2.799   1.684  1.00  4.08           O  
ATOM     47  CB  SER A  20      -4.644   4.334  -0.454  1.00 11.53           C  
ATOM     48  OG  SER A  20      -3.409   4.530  -1.113  1.00 16.31           O  
ATOM     49  N   ASN A  21      -5.747   4.723   2.514  1.00  1.10           N  
ATOM     50  CA  ASN A  21      -6.922   4.993   3.322  1.00  4.44           C  
ATOM     51  C   ASN A  21      -7.107   6.499   3.451  1.00  2.47           C  
ATOM     52  O   ASN A  21      -6.144   7.258   3.385  1.00  2.33           O  
ATOM     53  CB  ASN A  21      -6.807   4.379   4.719  1.00  6.05           C  
ATOM     54  CG  ASN A  21      -6.349   2.945   4.711  1.00 13.64           C  
ATOM     55  OD1 ASN A  21      -7.166   2.027   4.796  1.00 18.96           O  
ATOM     56  ND2 ASN A  21      -5.043   2.737   4.624  1.00 14.78           N  
ATOM     57  N   ASN A  22      -8.345   6.935   3.618  1.00  4.09           N  
ATOM     58  CA  ASN A  22      -8.587   8.312   3.991  1.00  7.10           C  
ATOM     59  C   ASN A  22      -9.865   8.468   4.801  1.00  3.66           C  
ATOM     60  O   ASN A  22     -10.734   7.596   4.829  1.00  4.58           O  
ATOM     61  CB  ASN A  22      -8.613   9.223   2.757  1.00  8.06           C  
ATOM     62  CG  ASN A  22      -9.787   8.962   1.858  1.00  9.67           C  
ATOM     63  OD1 ASN A  22     -10.915   9.343   2.168  1.00 10.31           O  
ATOM     64  ND2 ASN A  22      -9.533   8.324   0.723  1.00 16.48           N  
ATOM     65  N   PHE A  23      -9.948   9.598   5.482  1.00  3.73           N  
ATOM     66  CA  PHE A  23     -11.062   9.902   6.360  1.00  4.71           C  
ATOM     67  C   PHE A  23     -11.228  11.398   6.452  1.00  3.65           C  
ATOM     68  O   PHE A  23     -10.247  12.126   6.600  1.00  5.46           O  
ATOM     69  CB  PHE A  23     -10.845   9.317   7.757  1.00  9.78           C  
ATOM     70  CG  PHE A  23     -11.827   9.814   8.773  1.00 10.53           C  
ATOM     71  CD1 PHE A  23     -13.141   9.404   8.729  1.00 11.64           C  
ATOM     72  CD2 PHE A  23     -11.441  10.700   9.767  1.00 14.41           C  
ATOM     73  CE1 PHE A  23     -14.052   9.864   9.657  1.00 12.17           C  
ATOM     74  CE2 PHE A  23     -12.365  11.171  10.701  1.00 10.59           C  
ATOM     75  CZ  PHE A  23     -13.660  10.748  10.644  1.00 13.95           C  
ATOM     76  N   GLY A  24     -12.466  11.867   6.378  1.00  4.34           N  
ATOM     77  CA  GLY A  24     -12.697  13.295   6.439  1.00  9.11           C  
ATOM     78  C   GLY A  24     -14.068  13.679   6.917  1.00  7.16           C  
ATOM     79  O   GLY A  24     -14.981  12.851   6.983  1.00  5.56           O  
ATOM     80  N   ALA A  25     -14.191  14.956   7.260  1.00  8.33           N  
ATOM     81  CA  ALA A  25     -15.452  15.564   7.641  1.00 13.87           C  
ATOM     82  C   ALA A  25     -15.363  17.081   7.498  1.00 21.48           C  
ATOM     83  O   ALA A  25     -14.284  17.653   7.358  1.00 10.33           O  
ATOM     84  CB  ALA A  25     -15.825  15.187   9.058  1.00 15.88           C  
ATOM     85  OXT ALA A  25     -16.375  17.777   7.515  1.00 21.98           O  
TER      86      ALA A  25                                                      
ATOM     87  N   PHE B  15     -11.556  18.704   7.651  1.00 10.15           N  
ATOM     88  CA  PHE B  15     -10.238  18.099   7.652  1.00 10.31           C  
ATOM     89  C   PHE B  15     -10.214  16.927   6.692  1.00  9.13           C  
ATOM     90  O   PHE B  15     -11.245  16.503   6.166  1.00  9.88           O  
ATOM     91  CB  PHE B  15      -9.837  17.629   9.055  1.00 15.37           C  
ATOM     92  CG  PHE B  15     -10.739  16.566   9.612  1.00  9.48           C  
ATOM     93  CD1 PHE B  15     -11.801  16.903  10.425  1.00 13.50           C  
ATOM     94  CD2 PHE B  15     -10.547  15.232   9.292  1.00  9.60           C  
ATOM     95  CE1 PHE B  15     -12.639  15.934  10.931  1.00 16.23           C  
ATOM     96  CE2 PHE B  15     -11.384  14.260   9.785  1.00 12.15           C  
ATOM     97  CZ  PHE B  15     -12.426  14.610  10.611  1.00 17.31           C  
ATOM     98  N   LEU B  16      -9.023  16.388   6.501  1.00  8.90           N  
ATOM     99  CA  LEU B  16      -8.828  15.277   5.611  1.00  6.80           C  
ATOM    100  C   LEU B  16      -7.577  14.530   6.023  1.00  9.11           C  
ATOM    101  O   LEU B  16      -6.474  15.055   5.901  1.00 13.66           O  
ATOM    102  CB  LEU B  16      -8.736  15.780   4.177  1.00 14.60           C  
ATOM    103  CG  LEU B  16      -9.005  14.821   3.029  1.00 12.93           C  
ATOM    104  CD1 LEU B  16     -10.198  13.945   3.345  1.00 13.37           C  
ATOM    105  CD2 LEU B  16      -9.264  15.627   1.770  1.00 12.56           C  
ATOM    106  N   VAL B  17      -7.747  13.319   6.543  1.00  3.24           N  
ATOM    107  CA  VAL B  17      -6.617  12.493   6.947  1.00  6.08           C  
ATOM    108  C   VAL B  17      -6.412  11.409   5.879  1.00  2.79           C  
ATOM    109  O   VAL B  17      -7.370  10.912   5.289  1.00  2.55           O  
ATOM    110  CB  VAL B  17      -6.835  11.848   8.341  1.00  4.87           C  
ATOM    111  CG1 VAL B  17      -5.545  11.270   8.845  1.00  8.98           C  
ATOM    112  CG2 VAL B  17      -7.310  12.882   9.357  1.00  6.73           C  
ATOM    113  N   HIS B  18      -5.164  11.070   5.589  1.00  5.69           N  
ATOM    114  CA  HIS B  18      -4.883  10.067   4.562  1.00  3.94           C  
ATOM    115  C   HIS B  18      -3.574   9.357   4.834  1.00  4.26           C  
ATOM    116  O   HIS B  18      -2.669   9.922   5.447  1.00  3.45           O  
ATOM    117  CB  HIS B  18      -4.815  10.699   3.183  1.00  4.85           C  
ATOM    118  CG  HIS B  18      -3.722  11.703   3.049  1.00  9.77           C  
ATOM    119  ND1 HIS B  18      -2.549  11.437   2.379  1.00 14.52           N  
ATOM    120  CD2 HIS B  18      -3.613  12.967   3.518  1.00 14.89           C  
ATOM    121  CE1 HIS B  18      -1.767  12.500   2.432  1.00 11.60           C  
ATOM    122  NE2 HIS B  18      -2.389  13.442   3.118  1.00 12.20           N  
ATOM    123  N   SER B  19      -3.486   8.108   4.398  1.00  1.57           N  
ATOM    124  CA  SER B  19      -2.223   7.394   4.437  1.00  5.87           C  
ATOM    125  C   SER B  19      -2.149   6.325   3.375  1.00  2.51           C  
ATOM    126  O   SER B  19      -3.153   5.843   2.860  1.00  3.69           O  
ATOM    127  CB  SER B  19      -1.970   6.735   5.780  1.00 12.59           C  
ATOM    128  OG  SER B  19      -2.476   5.419   5.791  1.00 15.28           O  
ATOM    129  N   SER B  20      -0.923   5.936   3.078  1.00  3.51           N  
ATOM    130  CA  SER B  20      -0.710   4.886   2.121  1.00  5.22           C  
ATOM    131  C   SER B  20       0.574   4.144   2.456  1.00  2.14           C  
ATOM    132  O   SER B  20       1.468   4.676   3.122  1.00  2.10           O  
ATOM    133  CB  SER B  20      -0.669   5.458   0.701  1.00  8.58           C  
ATOM    134  OG  SER B  20       0.387   6.381   0.541  1.00 15.03           O  
ATOM    135  N   ASN B  21       0.633   2.896   2.026  1.00  2.41           N  
ATOM    136  CA  ASN B  21       1.802   2.059   2.191  1.00  3.66           C  
ATOM    137  C   ASN B  21       1.973   1.284   0.917  1.00  3.41           C  
ATOM    138  O   ASN B  21       0.997   0.946   0.270  1.00  4.56           O  
ATOM    139  CB  ASN B  21       1.637   1.101   3.361  1.00 11.64           C  
ATOM    140  CG  ASN B  21       1.145   1.787   4.611  1.00 11.31           C  
ATOM    141  OD1 ASN B  21       0.002   1.600   5.020  1.00 18.14           O  
ATOM    142  ND2 ASN B  21       2.016   2.575   5.239  1.00  9.13           N  
ATOM    143  N   ASN B  22       3.203   0.970   0.556  1.00  1.73           N  
ATOM    144  CA  ASN B  22       3.391   0.019  -0.507  1.00  2.26           C  
ATOM    145  C   ASN B  22       4.731  -0.650  -0.362  1.00  3.01           C  
ATOM    146  O   ASN B  22       5.616  -0.151   0.334  1.00  2.93           O  
ATOM    147  CB  ASN B  22       3.245   0.685  -1.872  1.00  7.99           C  
ATOM    148  CG  ASN B  22       4.226   1.799  -2.088  1.00  8.43           C  
ATOM    149  OD1 ASN B  22       3.881   2.974  -1.981  1.00 17.19           O  
ATOM    150  ND2 ASN B  22       5.455   1.445  -2.421  1.00 13.41           N  
ATOM    151  N   PHE B  23       4.852  -1.817  -0.973  1.00  3.37           N  
ATOM    152  CA  PHE B  23       6.150  -2.411  -1.150  1.00  3.19           C  
ATOM    153  C   PHE B  23       6.149  -3.132  -2.471  1.00  2.63           C  
ATOM    154  O   PHE B  23       5.096  -3.460  -3.020  1.00  5.68           O  
ATOM    155  CB  PHE B  23       6.535  -3.355   0.008  1.00  8.34           C  
ATOM    156  CG  PHE B  23       5.770  -4.656   0.042  1.00 11.99           C  
ATOM    157  CD1 PHE B  23       6.253  -5.786  -0.613  1.00  9.99           C  
ATOM    158  CD2 PHE B  23       4.591  -4.758   0.762  1.00 12.38           C  
ATOM    159  CE1 PHE B  23       5.556  -6.980  -0.573  1.00 12.60           C  
ATOM    160  CE2 PHE B  23       3.883  -5.944   0.804  1.00 14.52           C  
ATOM    161  CZ  PHE B  23       4.369  -7.056   0.140  1.00 12.82           C  
ATOM    162  N   GLY B  24       7.339  -3.356  -2.997  1.00  3.14           N  
ATOM    163  CA  GLY B  24       7.452  -4.130  -4.217  1.00  4.90           C  
ATOM    164  C   GLY B  24       8.839  -4.671  -4.424  1.00  5.67           C  
ATOM    165  O   GLY B  24       9.753  -4.391  -3.652  1.00  3.97           O  
ATOM    166  N   ALA B  25       8.959  -5.491  -5.467  1.00  7.68           N  
ATOM    167  CA  ALA B  25      10.232  -5.974  -5.984  1.00  6.17           C  
ATOM    168  C   ALA B  25      10.064  -6.456  -7.419  1.00 13.87           C  
ATOM    169  O   ALA B  25       8.948  -6.581  -7.923  1.00 13.92           O  
ATOM    170  CB  ALA B  25      10.797  -7.090  -5.105  1.00  5.14           C  
ATOM    171  OXT ALA B  25      11.042  -6.713  -8.120  1.00 12.43           O  
TER     172      ALA B  25                                                      
HETATM  173  S   SCN B 101      -7.246   7.684   7.225  1.00 19.29           S  
HETATM  174  C   SCN B 101      -5.643   7.082   7.775  1.00 13.65           C  
HETATM  175  N   SCN B 101      -4.579   6.683   8.109  1.00 20.06           N  
HETATM  176  O   HOH A 101     -18.396  18.327   6.534  1.00 12.95           O  
HETATM  177  O   HOH A 102      -3.537   1.897  -2.962  1.00 11.85           O  
HETATM  178  O   HOH B 201      -1.807   9.308   1.677  1.00 10.52           O  
HETATM  179  O   HOH B 202      13.443  -5.871  -8.944  1.00  8.46           O  
HETATM  180  O   HOH B 203       5.252  -0.050   3.032  1.00 12.87           O  
HETATM  181  O   HOH B 204      -4.644  16.045   3.680  1.00 14.49           O  
CONECT  173  174                                                                
CONECT  174  173  175                                                           
CONECT  175  174                                                                
MASTER      192    0    1    0    2    0    1    6  179    2    3    2          
END                                                                             
